Screener
The Beauty Health Company SKIN Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 66.4%+4.9pp | 64.9%+8.3pp | 65.3%+10.8pp | 64.8%+14.3pp | 61.5%+28.1pp | |
| Operating margin | -1.5%+12.5pp | -3.6%+15.8pp | -7%+13.3pp | -9.3%+13.4pp | -14%+24.1pp | |
| Net margin | -9.8%-3.7pp | -2%+9.9pp | -3.2%+5.5pp | -3.9%+4.2pp | -6.1%+16.7pp | |
| Returns | ||||||
| Return on equity | -43.9%-17.3pp | -12%+58.5pp | -16.9%+35.5pp | -18.7%+18.9pp | -26.5%+45.9pp | |
| Efficiency | ||||||
| Asset turnover | 0.6×+0.1× | 0.5×+0.1× | 0.5×+0.1× | 0.5×+0.1× | 0.5×+0.1× | |
| Liquidity | ||||||
| Current ratio | 1.8×-3.4× | 1.8×-5.7× | 1.7×-5.3× | 5×-1.6× | 5.1×-1.3× | |
| Leverage | ||||||
| Debt-to-equity | 2.2×-2.8× | 2.3×+2.0× | 2.3×-8.7× | 5.8×+5.5× | 5.1×+4.8× | |
| Net debt / EBITDA | -5.4×— | -8.6×— | —— | —— | —— | |
| Per Share | ||||||
| Book value per share | $0.43-18.7% | $0.42+14.1% | $0.45+23.7% | $0.52+7.5% | $0.53+8.2% | |
| Valuation | ||||||
| Market capitalization | $89.15M-65.7% | $113.72M-32.2% | $177.23M-10.2% | $252.38M+41.7% | $241.91M+2.3% | |
| Price / sales | 0.3×-0.5× | 0.4×-0.1× | 0.6×0.0× | 0.8×+0.3× | 0.8×+0.1× | |
| Price / book | 1.6×-1.9× | 2.1×-1.6× | 2.9×-0.9× | 3.8×+0.9× | 3.3×-0.1× | |
| EV / EBITDA | 0.5×— | 3.8×— | —— | —— | —— |
FAQ
- What are The Beauty Health Company's profit margins?
- The Beauty Health Company (SKIN) runs a 66.4% gross margin and a -1.5% operating margin, with a -9.8% net margin.
- Where do The Beauty Health Company's ratios come from?
- Every ratio is computed from The Beauty Health Company's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
